- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
PARS Market Currents
more »
Currently, there are no Market Currents on PARS.
PARS in Focus
more »
PARS Related Articles
more »
PARS News
more »
Currently, there are no news on PARS.
PARS Press Releases and Filings
more »
Currently, there are no press releases or filings on PARS.
PARS Latest Transcript
more »
Currently, there are no transcripts for PARS.
PARS Cramer
more »
Currently, there are no Cramer articles on PARS.
PARS Instablog posts
more »
PARS vs. ETF Alternatives
Company Description
Pharmos Corporation (the Company or Pharmos) is a biopharmaceutical company that discovers and develops novel therapeutics to treat a range of diseases of the nervous system, including disorders of the brain-gut axis (e.g., Irritable Bowel Syndrome), with a focus on pain/inflammation, and... More
